Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Med Mycol ; 58(8): 1138-1148, 2020 Nov 10.
Article in English | MEDLINE | ID: mdl-32246714

ABSTRACT

Members of the C. neoformans/C. gattiii species complex are an important cause of serious humans infections, including meningoencephalitis. We describe here a 45 kDa extracellular cellulase purified from culture supernatants of C. neoformans var. neoformans. The N-terminal sequence obtained from the purified protein was used to isolate a clone containing the full-length coding sequence from a C. neoformans var. neoformans (strain B-3501A) cDNA library. Bioinformatics analysis indicated that this gene is present, with variable homology, in all sequenced genomes of the C. neoformans/C. gattii species complex. The cDNA clone was used to produce a recombinant 45 kDa protein in E. coli that displayed the ability to convert carboxymethyl cellulose and was therefore designated as NG-Case (standing for Neoformans Gattii Cellulase). To explore its potential use as a vaccine candidate, the recombinant protein was used to immunize mice and was found capable of inducing T helper type 1 responses and delayed-type hypersensitivity reactions, but not immune protection against a highly virulent C. neoformans var grubii strain. These data may be useful to better understand the mechanisms underlying the ability C. neoformans/C. gattii to colonize plant habitats and to interact with the human host during infection.


Subject(s)
Cellulase/immunology , Cryptococcus/enzymology , Fungal Proteins/immunology , Animals , Carboxymethylcellulose Sodium/metabolism , Cellulase/chemistry , Cellulase/genetics , Cellulase/metabolism , Cryptococcosis/immunology , Cryptococcosis/microbiology , Cryptococcus/genetics , Cryptococcus/immunology , Cryptococcus/metabolism , Cryptococcus neoformans/enzymology , Cryptococcus neoformans/genetics , Cryptococcus neoformans/immunology , Cryptococcus neoformans/metabolism , Culture Media, Conditioned , Cytokines/immunology , Fungal Proteins/chemistry , Fungal Proteins/genetics , Fungal Proteins/metabolism , Immunization , Mice , Molecular Weight , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/metabolism , Th1 Cells/immunology
2.
J Immunol ; 204(3): 660-670, 2020 02 01.
Article in English | MEDLINE | ID: mdl-31852751

ABSTRACT

The influx of neutrophils to infection sites is a fundamental step in host defenses against the frequent human pathogen group B Streptococcus (GBS) and other extracellular bacteria. Using a mouse model of GBS-induced peritonitis, we show in this study that the chemokines Cxcl1 and Cxcl2 play distinctive roles in enhancing the recruitment and the antibacterial activities of neutrophils in a manner that is linked to differences in the cellular sources of these mediators. Cell depletion experiments demonstrated that neutrophils make a significant contribution to the in vivo production of Cxcl2 but not Cxcl1. In vitro, neutrophils responded weakly to LPS but released high levels of Cxcl2 after stimulation with GBS or other bacteria. Neutrophil-derived Cxcl2 acted in an autocrinous manner to increase its own production and to enhance antibacterial activities, including the release of oxygen radicals. In both neutrophils and macrophages, the production of Cxcl1/2 largely required the presence of functional UNC93B1, a chaperone protein involved in signaling by endosomal TLRs. Moreover, the phenotype of UNC93B1-defective phagocytes could be recapitulated by the simultaneous absence of TLR7, 9, and 13 but not by the absence of individual TLRs. Collectively, our data show that neutrophils recognize Gram-positive and Gram-negative bacteria by means of multiple phagosomal TLRs, resulting in de novo synthesis of Cxcl2, amplification of neutrophil recruitment, and potentiation of their antibacterial activities. These data may be useful to devise alternative therapeutic strategies aimed at enhancing the recruitment and the functional activities of polymorphonuclear leukocytes during infections caused by antibiotic-resistant bacteria.


Subject(s)
Bacterial Infections/immunology , Chemokine CXCL2/metabolism , Endosomes/metabolism , Neutrophils/immunology , Peritonitis/immunology , Animals , Disease Models, Animal , Female , Humans , Immunity, Innate , Mice , Mice, Inbred C57BL , Mice, Knockout , Neutrophil Infiltration , Toll-Like Receptors/metabolism
3.
Mol Microbiol ; 110(1): 82-94, 2018 10.
Article in English | MEDLINE | ID: mdl-30030946

ABSTRACT

Binding of microbial pathogens to host vitronectin (Vtn) is a common theme in the pathogenesis of invasive infections. In this study, we characterized the role of Vtn in the invasion of mucosal epithelial cells by Streptococcus agalactiae (i.e. group B streptococcus or GBS), a frequent human pathogen. Moreover, we identified PbsP, a previously described plasminogen-binding protein of GBS, as a dual adhesin that can also interact with human Vtn through its streptococcal surface repeat (SSURE) domains. Deletion of the pbsP gene decreases both bacterial adhesion to Vtn-coated inert surfaces and the ability of GBS to interact with epithelial cells. Bacterial adherence to and invasion of epithelial cells were either inhibited or enhanced by cell pretreatment with, respectively, anti-Vtn antibodies or Vtn, confirming the role of Vtn as a GBS ligand on host cells. Finally, antibodies directed against the integrin αv subunit inhibited Vtn-dependent cell invasion by GBS. Collectively, these results indicate that Vtn acts as a bridge between the SSURE domains of PbsP on the GBS surface and host integrins to promote bacterial invasion of epithelial cells. Therefore, inhibition of interactions between PbsP and extracellular matrix components could represent a viable strategy to prevent colonization and invasive disease by GBS.


Subject(s)
Bacterial Proteins/metabolism , Integrin alphaV/metabolism , Streptococcal Infections/microbiology , Streptococcus agalactiae/metabolism , Streptococcus agalactiae/pathogenicity , Vitronectin/metabolism , A549 Cells , Bacterial Adhesion/genetics , Bacterial Proteins/genetics , Caco-2 Cells , Cell Wall/metabolism , Epithelial Cells/microbiology , Humans , Integrin alphaV/genetics , Protein Domains , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Streptococcus agalactiae/genetics , Vitronectin/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...